Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 USD | +3.45% | -0.55% | -20.00% |
05-13 | Oppenheimer Adjusts Vor Biopharma Price Target to $10 From $15, Maintains Outperform Rating | MT |
05-09 | Vor Biopharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VOR BIOPHARMA INC. | Other Biotechnology & Medical Research | +3.45% | -0.55% | -20.00% | -60.87% | - | 119M |
Technical Rankings Surperformance
- Stock Market
- Equities
- VOR Stock
- Charts Vor Biopharma Inc.
- Comparison Chart